Lymphoma Vaccine Trial: One Step Forward In a Long Trek


September 15, 2009

Journal of the National Cancer Institute

Research led by Stephen Schuster, MD, an associate professor in the division of Hematology-Oncology, is highlighted in a Journal of the National Cancer Institute article detailing the trial results he presented at this year's American Society of Clinical Oncology. Results showed that a personalized cancer vaccine made from a patient's own tumor cell improved progression-free survival among patients with follicular lymphoma... Read More